Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
J Med Genet. 2018 Oct;55(10):669-674. doi: 10.1136/jmedgenet-2017-104962. Epub 2018 Jan 12.
BACKGROUND: In approximately 10% of all gastric cancer (GC) cases, a heritable cause is suspected. A subset of these cases have a causative germline mutation; however, in most cases the cause remains unknown. Our objective was to assess to what extent these remaining cases may be explained by germline mutations in the novel candidate GC predisposing genes , or . METHODS: We sequenced a large cohort of unexplained young and/or familial patients with GC (n=286) without a germline mutation for germline variants affecting , and using a targeted next-generation sequencing approach based on single-molecule molecular inversion probes. RESULTS: Predicted deleterious germline variants were not encountered in , but recurrently observed in (n=2) and (n=3) in our cohort of patients with GC. In contrast to deleterious variants in , deleterious variants in also occur frequently in the general population. CONCLUSIONS: Based on our results should no longer be considered a GC predisposition gene, whereas deleterious variants are confirmed as an infrequent cause of GC susceptibility. Biallelic germline mutations are at most a very rare cause of GC susceptibility as no additional cases were identified.
背景:在大约 10%的所有胃癌(GC)病例中,怀疑存在遗传性病因。这些病例中有一部分存在致病的种系突变;然而,在大多数情况下,病因仍然未知。我们的目的是评估这些剩余病例在多大程度上可以用新型候选 GC 易感性基因 或 的种系突变来解释。
方法:我们使用基于单分子分子反转探针的靶向下一代测序方法,对 286 名无种系突变的不明原因的年轻和/或家族性 GC 患者(n=286)进行了种系变异影响 和 的测序。
结果:在我们的 GC 患者队列中,未发现 中的预测性有害种系变异,但在 (n=2)和 (n=3)中反复观察到。与 中的有害变异不同, 中的有害变异在普通人群中也经常发生。
结论:基于我们的结果, 不应再被视为 GC 易感性基因,而 中的有害变异被确认为 GC 易感性的罕见原因。双等位基因 种系突变最多是 GC 易感性的非常罕见原因,因为没有发现其他病例。
J Med Genet. 2018-1-12
PLoS Genet. 2014-10-23
Eur J Med Genet. 2021-10
Semin Oncol. 2016-10
Gastric Cancer. 2018-12-4
Best Pract Res Clin Gastroenterol. 2014-12
Cancer Treat Res. 2024
Cancers (Basel). 2023-8-29
J Cancer. 2023-1-1
J Pers Med. 2022-12-8
J Surg Oncol. 2022-6
Gastroenterol Hepatol Bed Bench. 2021
Int J Mol Sci. 2021-1-28
Nature. 2016-8-18
JAMA Oncol. 2015-4
PLoS Genet. 2014-10-23
Bioinformatics. 2014-9-15